Perceptive Advisors’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Perceptive Advisors’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-641,364	Closed	-$23.3M	–	233
2016 Q4	$23.3M	Buy	641,364 +89,334	+16%	+$3.16M	1.66%	15
2016 Q3	$21.1M	Buy	+552,030	New	+$8.16M	1.36%	14

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Perceptive Advisors's CLCD Position: Q1 2017 in Review

Perceptive Advisors sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 641,364 shares — an estimated $23.3M sold.

Perceptive Advisors first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $23.3M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Perceptive Advisors reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Perceptive Advisors sold 641,364 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $23.3M.
Perceptive Advisors first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Perceptive Advisors's CoLucid Pharmaceuticals, Inc. position peaked at $23.3M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.